H

Researcher Profile

Heribert Staudinger

🏛 Sanofi, Bridgewater, New Jersey

4

Publications

1,814

Citations

10

Co-Authors

4

Active Years

Publications

Open Access Journal Article ERJ Open Research May 09, 2024

AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD

Klaus F. Rabe · Fernando J. Martinez · Surya P. Bhatt · Tomotaka Kawayama +14 more

10.1183/23120541.00718-2023 28 citations

Journal Article JAMA Dermatology Jan 01, 2020

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis

Eric L. Simpson · Amy S. Paller · Elaine C. Siegfried · Mark Boguniewicz +23 more

10.1001/jamadermatol.2019.3336 451 citations

Journal Article The Lancet Nov 01, 2019

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert · Joseph K Han · Martin Desrosiers · Peter W Hellings +30 more

10.1016/s0140-6736(19)31881-1 1,261 citations

Journal Article American Review of Respiratory Disease Jul 01, 1990

Twenty-four Hour Lung Function in Adult Patients with Asthma: Chronoptimized Theophylline Therapy Once-daily Dosing in the Evening versus Conventional Twice-daily Dosing

Gilbert E. D'Alonzo · Michael H. Smolensky · Stuart Feldman · Leslie A. Gianotti +3 more

10.1164/ajrccm/142.1.84 74 citations

Publication Timeline

2024

1

2020

1

2019

1

1990

1

Frequent Co-Authors

Gianluca Pirozzi

Hélène Goulaouic

George D. Yancopoulos

Mark Boguniewicz